MorphoSys AG Reports Non-Cash Impairment Charge of € 231 Million on Goodwill After Consolidation of Research and Discovery Functions; Corresponding Increase of Group Operating Expenses in 2021

3 years ago

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014PLANEGG and MUNICH, GERMANY…

IQAI’s Sponsored Phase I Clinical Trial is Open

3 years ago

MILWAUKEE, WI / ACCESSWIRE / March 10, 2022 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) is pleased to announce that the sponsored…

Emerging Technology Insider Releases a New TechTalks Video Interview Featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc.

3 years ago

Discussions Centered on the Expanding Partnership Between Pressure BioSciences & The Ohio State University, the Food Industry Consortium, and the…

Medisafe Expands Executive Leadership to Support Continued Growth

3 years ago

New chief strategy officer, chief financial officer to drive business partnershipsBOSTON, MA / ACCESSWIRE / March 10, 2022 / Medisafe,…

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate

3 years ago

Moderna's Omicron-specific bivalent booster candidate (mRNA-1273.214) combines Moderna's Omicron-specific booster candidate (mRNA-1273.529) and the Moderna COVID-19 vaccine (mRNA-1273)Moderna expects to…

Moderna to Host Third Annual Virtual Vaccines Day on March 24, 2022

3 years ago

CAMBRIDGE, MA / ACCESSWIRE / March 10, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Goodbody Health Confirms Strong 2021 Revenue Continuing into 2022

3 years ago

VANCOUVER, BC / ACCESSWIRE / March 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is…

CBD Life Sciences, Inc. (CBDL) Set to Present at ERRL Cup Cannabis Event

3 years ago

SCOTTSDALE, AZ / ACCESSWIRE / March 10, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary,…

NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments

3 years ago

Completed concrete milestones in its strategy to become a leading psychedelic drug developer and specialty clinics operator. Developed clear drug…

Zealand Pharma convenes its Annual General Meeting 2022

3 years ago

Company Announcement – No. 8 / 2022 Zealand Pharma convenes its Annual General Meeting 2022 Copenhagen, 10 March, 2022 – Zealand Pharma…